tiprankstipranks
Trending News
More News >
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market

Eton Pharmaceuticals (ETON) Income Statement

Compare
463 Followers

Eton Pharmaceuticals Income Statement

Last quarter (Q4 2024), Eton Pharmaceuticals's total revenue was $11.65M, an increase of 59.26% from the same quarter last year. In Q4, Eton Pharmaceuticals's net income was $-598.00K. See Eton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 39.01M$ 31.64M$ 21.25M$ 21.83M$ 39.00K
Gross Profit
$ 23.41M$ 21.06M$ 14.32M$ 19.21M$ -247.00K
Operating Expenses
$ 26.01M$ 22.25M$ 22.58M$ 20.70M$ 26.86M
Depreciation and Amortization
$ 0.00$ 901.00K$ 1.76M$ 447.00K$ 651.00K
EBITDA
$ -2.60M$ -291.00K$ -6.49M$ -1.12M$ -26.46M
Operating Income
$ -2.60M$ -1.19M$ -8.26M$ -1.50M$ -27.11M
Other Income/Expenses
$ -1.21M$ 503.00K$ -761.00K$ -460.00K$ -859.00K
Pretax Income
$ -3.81M$ -689.00K$ -9.02M$ -1.96M$ -27.97M
Net Income
$ -3.82M$ -936.00K$ -9.78M$ -2.96M$ -28.83M
Per Share Metrics
Basic EPS
$ -0.15$ -0.04$ -0.39$ -0.12$ -1.37
Diluted EPS
$ -0.15$ -0.04$ -0.39$ -0.12$ -1.37
Weighted Average Shares Outstanding
25.89M 25.64M 25.15M 25.21M 21.01M
Weighted Average Shares Outstanding (Diluted)
25.89M 25.65M 25.15M 25.21M 21.01M
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis